Sarah Sammons MD
@drsarahsammons.bsky.social
Breast Medical Oncologist
Associate Director Metastatic Breast Program
Dana Farber Cancer Institute
Harvard Medical School
#oncsky #cansky #medsky
Associate Director Metastatic Breast Program
Dana Farber Cancer Institute
Harvard Medical School
#oncsky #cansky #medsky
Reposted by Sarah Sammons MD
America cannot long remain free, nor first among nations, if it becomes the kind of place where universities are dismantled because they don't align politically with the current head of the government.
May 23, 2025 at 4:00 PM
America cannot long remain free, nor first among nations, if it becomes the kind of place where universities are dismantled because they don't align politically with the current head of the government.
Reposted by Sarah Sammons MD
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
May 23, 2025 at 10:05 AM
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
Reposted by Sarah Sammons MD
The purpose of the #ASPRIA trial is to determine if a combination of two drugs, #Atezolizumab and #SacituzumabGovitecan, can be used to prevent recurrence in #TripleNegativeBreastCancer.
For more information call 877-338-7425 or visit:
www.dana-farber.org/clinical-tri...
#BreastCancer #TNBC
For more information call 877-338-7425 or visit:
www.dana-farber.org/clinical-tri...
#BreastCancer #TNBC
May 20, 2025 at 2:45 PM
The purpose of the #ASPRIA trial is to determine if a combination of two drugs, #Atezolizumab and #SacituzumabGovitecan, can be used to prevent recurrence in #TripleNegativeBreastCancer.
For more information call 877-338-7425 or visit:
www.dana-farber.org/clinical-tri...
#BreastCancer #TNBC
For more information call 877-338-7425 or visit:
www.dana-farber.org/clinical-tri...
#BreastCancer #TNBC
Reposted by Sarah Sammons MD
Join us via Zoom on 6/24 for OABC’s Lunch & Learn Educational Series: Understanding the Role of Medical Cannabis in Cancer Care with psychiatrist, Ilana Braun, MD.
dfci.zoom.us/meeting/regi...
dfci.zoom.us/meeting/regi...
May 20, 2025 at 1:11 PM
Join us via Zoom on 6/24 for OABC’s Lunch & Learn Educational Series: Understanding the Role of Medical Cannabis in Cancer Care with psychiatrist, Ilana Braun, MD.
dfci.zoom.us/meeting/regi...
dfci.zoom.us/meeting/regi...
Reposted by Sarah Sammons MD
💙 This #NationalNursesWeek, we are proud to honor the extraordinary Oncology Nurse Navigators at Dana-Farber—trusted allies who walk with patients through some of life’s most difficult moments.
We are deeply grateful for all they do—and for every Dana-Farber nurse who leads with heart.
We are deeply grateful for all they do—and for every Dana-Farber nurse who leads with heart.
May 10, 2025 at 11:45 AM
💙 This #NationalNursesWeek, we are proud to honor the extraordinary Oncology Nurse Navigators at Dana-Farber—trusted allies who walk with patients through some of life’s most difficult moments.
We are deeply grateful for all they do—and for every Dana-Farber nurse who leads with heart.
We are deeply grateful for all they do—and for every Dana-Farber nurse who leads with heart.
Reposted by Sarah Sammons MD
Join us via zoom 5/16 for an educational session on how circulating tumor DNA is used to inform treatment selection and monitor response in #metastaticbreastcancer with Dr. Heather Parsons @heatherparsons.bsky.social, part of the EMBRACE #MBC Virtual Forum Series.
www.dana-farber.org/metastatic-b...
www.dana-farber.org/metastatic-b...
May 1, 2025 at 7:32 PM
Join us via zoom 5/16 for an educational session on how circulating tumor DNA is used to inform treatment selection and monitor response in #metastaticbreastcancer with Dr. Heather Parsons @heatherparsons.bsky.social, part of the EMBRACE #MBC Virtual Forum Series.
www.dana-farber.org/metastatic-b...
www.dana-farber.org/metastatic-b...
Reposted by Sarah Sammons MD
Congratulations to Drs. Paolo Tarantino, Caterina Sposetti, Pietro De Placido, and Tess O'Meara on receiving the prestigious #ConquerCancer #ASCO Merit Awards!
@ptarantinomd.bsky.social @csposettimd.bsky.social
@ptarantinomd.bsky.social @csposettimd.bsky.social
April 25, 2025 at 12:43 PM
Congratulations to Drs. Paolo Tarantino, Caterina Sposetti, Pietro De Placido, and Tess O'Meara on receiving the prestigious #ConquerCancer #ASCO Merit Awards!
@ptarantinomd.bsky.social @csposettimd.bsky.social
@ptarantinomd.bsky.social @csposettimd.bsky.social
Reposted by Sarah Sammons MD
April 17, 2025 at 5:55 PM
Reposted by Sarah Sammons MD
Did you know? 99% of all new medications resulted from federally-funded university research through #NIH
Learn more about #ResearchSavesLives: hub.jhu.edu/research-sav....
Learn more about #ResearchSavesLives: hub.jhu.edu/research-sav....
April 16, 2025 at 8:31 PM
Did you know? 99% of all new medications resulted from federally-funded university research through #NIH
Learn more about #ResearchSavesLives: hub.jhu.edu/research-sav....
Learn more about #ResearchSavesLives: hub.jhu.edu/research-sav....
Such a great session!
Dr. Sarah Sammons speaks about the importance of communication for building the bond of trust between a patient and physician. Watch the whole conversation with Dr. Sammons and her Patient, Lisa, on our website. Just click here: www.infinitestrength.org/blog/metasta...
April 15, 2025 at 10:27 PM
Such a great session!
Reposted by Sarah Sammons MD
In a multivariable analysis, omitting ET was associated w/⬆️ risk of death HR 1.23; For ER 1%-5% HR 1.16; For ER 6%-10% HR 1.42
Endocrine Therapy Omission in ER–Low (1%-10%) Early-Stage Breast Cancer | @oncoalert.bsky.social
ascopubs.org/doi/10.1200/...
Endocrine Therapy Omission in ER–Low (1%-10%) Early-Stage Breast Cancer | @oncoalert.bsky.social
ascopubs.org/doi/10.1200/...
Endocrine Therapy Omission in Estrogen Receptor–Low (1%-10%) Early-Stage Breast Cancer
PURPOSEAdjuvant endocrine therapy (ET) improves overall survival (OS) in estrogen receptor
(ER)–positive early-stage breast cancer (BC). However, the benefit of ET for those
with ER-low BC (ER 1%-10%)...
ascopubs.org
April 13, 2025 at 12:44 PM
In a multivariable analysis, omitting ET was associated w/⬆️ risk of death HR 1.23; For ER 1%-5% HR 1.16; For ER 6%-10% HR 1.42
Endocrine Therapy Omission in ER–Low (1%-10%) Early-Stage Breast Cancer | @oncoalert.bsky.social
ascopubs.org/doi/10.1200/...
Endocrine Therapy Omission in ER–Low (1%-10%) Early-Stage Breast Cancer | @oncoalert.bsky.social
ascopubs.org/doi/10.1200/...
Reposted by Sarah Sammons MD
This retrospective study looked at real-world outcomes with #SacituzumabGovitecan among #BreastCancer pts with #CentralNervousSystem metastases.
🔓https://pubmed.ncbi.nlm.nih.gov/40038301/
✍️@antgiordanomd.bsky.social @stolaney1.bsky.social @drsarahsammons.bsky.social #LMD #CNS #MBC #leptomeningeal
🔓https://pubmed.ncbi.nlm.nih.gov/40038301/
✍️@antgiordanomd.bsky.social @stolaney1.bsky.social @drsarahsammons.bsky.social #LMD #CNS #MBC #leptomeningeal
April 7, 2025 at 5:06 PM
This retrospective study looked at real-world outcomes with #SacituzumabGovitecan among #BreastCancer pts with #CentralNervousSystem metastases.
🔓https://pubmed.ncbi.nlm.nih.gov/40038301/
✍️@antgiordanomd.bsky.social @stolaney1.bsky.social @drsarahsammons.bsky.social #LMD #CNS #MBC #leptomeningeal
🔓https://pubmed.ncbi.nlm.nih.gov/40038301/
✍️@antgiordanomd.bsky.social @stolaney1.bsky.social @drsarahsammons.bsky.social #LMD #CNS #MBC #leptomeningeal
How does SG perform in active BC brain metastases?
Sacituzumab govitecan (SG) in 33 patients with HER2-negative MBC and CNS metastases, including active and LMD had a modest CNS ORR of 4/30 (13%) and median CNS-PFS of 2.9 months (95%CI:2.0-4.3).
pubmed.ncbi.nlm.nih.gov/40038301/
Sacituzumab govitecan (SG) in 33 patients with HER2-negative MBC and CNS metastases, including active and LMD had a modest CNS ORR of 4/30 (13%) and median CNS-PFS of 2.9 months (95%CI:2.0-4.3).
pubmed.ncbi.nlm.nih.gov/40038301/
Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastases - PubMed
Central nervous system (CNS) metastases are associated with poor prognosis in patients with metastatic breast cancer (MBC). In this retrospective study, we investigated the activity of sacituzumab gov...
pubmed.ncbi.nlm.nih.gov
April 6, 2025 at 3:10 PM
How does SG perform in active BC brain metastases?
Sacituzumab govitecan (SG) in 33 patients with HER2-negative MBC and CNS metastases, including active and LMD had a modest CNS ORR of 4/30 (13%) and median CNS-PFS of 2.9 months (95%CI:2.0-4.3).
pubmed.ncbi.nlm.nih.gov/40038301/
Sacituzumab govitecan (SG) in 33 patients with HER2-negative MBC and CNS metastases, including active and LMD had a modest CNS ORR of 4/30 (13%) and median CNS-PFS of 2.9 months (95%CI:2.0-4.3).
pubmed.ncbi.nlm.nih.gov/40038301/
Reposted by Sarah Sammons MD
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis academic.oup.com/oncolo/artic...
#SuppOnc #DatoDXd @hoperugo.bsky.social
#SuppOnc #DatoDXd @hoperugo.bsky.social
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis
Abstract. Oral mucositis/stomatitis (hereafter stomatitis) is a common dose-limiting toxicity seen with various classes of cancer treatment. Symptoms assoc
academic.oup.com
April 5, 2025 at 1:04 AM
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis academic.oup.com/oncolo/artic...
#SuppOnc #DatoDXd @hoperugo.bsky.social
#SuppOnc #DatoDXd @hoperugo.bsky.social
Many friends would moonlight to afford childcare during residency. The problem is for all working class US citizens.
🚨This study is important.
Studying barriers to optimal training is part of improving the workforce & changing medicine's culture.
This focus shows we ARE making progress toward our goal of having excellent medical care —and also healthy & happy physicians to provide it.
@oncoalert.bsky.social
Studying barriers to optimal training is part of improving the workforce & changing medicine's culture.
This focus shows we ARE making progress toward our goal of having excellent medical care —and also healthy & happy physicians to provide it.
@oncoalert.bsky.social
‘Virtually impossible to afford childcare’ on single-parent resident salary
Combined living expenses and childcare costs could not be sustained on the salary of a single-parent surgical resident, according to study results published in JAMA Network Open.Individuals may be det...
www.healio.com
April 2, 2025 at 10:54 AM
Many friends would moonlight to afford childcare during residency. The problem is for all working class US citizens.
Reposted by Sarah Sammons MD
🚨This study is important.
Studying barriers to optimal training is part of improving the workforce & changing medicine's culture.
This focus shows we ARE making progress toward our goal of having excellent medical care —and also healthy & happy physicians to provide it.
@oncoalert.bsky.social
Studying barriers to optimal training is part of improving the workforce & changing medicine's culture.
This focus shows we ARE making progress toward our goal of having excellent medical care —and also healthy & happy physicians to provide it.
@oncoalert.bsky.social
‘Virtually impossible to afford childcare’ on single-parent resident salary
Combined living expenses and childcare costs could not be sustained on the salary of a single-parent surgical resident, according to study results published in JAMA Network Open.Individuals may be det...
www.healio.com
April 1, 2025 at 5:21 PM
🚨This study is important.
Studying barriers to optimal training is part of improving the workforce & changing medicine's culture.
This focus shows we ARE making progress toward our goal of having excellent medical care —and also healthy & happy physicians to provide it.
@oncoalert.bsky.social
Studying barriers to optimal training is part of improving the workforce & changing medicine's culture.
This focus shows we ARE making progress toward our goal of having excellent medical care —and also healthy & happy physicians to provide it.
@oncoalert.bsky.social
Reposted by Sarah Sammons MD
Like I said, change is a good thing. Sad to leave Brown University Health but super excited to join such a venerable institution as @tuftsmedschool.bsky.social
March 31, 2025 at 7:27 PM
Like I said, change is a good thing. Sad to leave Brown University Health but super excited to join such a venerable institution as @tuftsmedschool.bsky.social
Will AI write chemo orders, do insurance prior auths, write for prescription drugs, take care of hospitalized patients and run to infusion reactions?
My word I would love to see it!
people.com/bill-gates-a...
My word I would love to see it!
people.com/bill-gates-a...
Bill Gates Says AI Will Replace Doctors, Teachers and More in Next 10 Years, Making Humans Unnecessary 'for Most Things'
Bill Gates believes that AI will replace doctors, teachers and more professionals within the decade, leaving humans unnecessary 'for most things.' He shared his take on AI and vision for the future on...
people.com
March 29, 2025 at 6:39 PM
Will AI write chemo orders, do insurance prior auths, write for prescription drugs, take care of hospitalized patients and run to infusion reactions?
My word I would love to see it!
people.com/bill-gates-a...
My word I would love to see it!
people.com/bill-gates-a...
Reposted by Sarah Sammons MD
What’s the role of PET in breast cancer?
18F-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer | Journal of Clinical Oncology ascopubs.org/doi/full/10....
18F-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer | Journal of Clinical Oncology ascopubs.org/doi/full/10....
<sup>18</sup>F-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer
ascopubs.org
March 27, 2025 at 10:08 AM
What’s the role of PET in breast cancer?
18F-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer | Journal of Clinical Oncology ascopubs.org/doi/full/10....
18F-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer | Journal of Clinical Oncology ascopubs.org/doi/full/10....
Reposted by Sarah Sammons MD
🚨Does Vaping Cause Lung Cancer? Myths and Facts🚨
14.1% of young adults (18-25) — around 4.7 million people — are vaping, putting their health at serious risk. Studies show that vaping combined with smoking increases the risk of lung cancer 4x.
14.1% of young adults (18-25) — around 4.7 million people — are vaping, putting their health at serious risk. Studies show that vaping combined with smoking increases the risk of lung cancer 4x.
March 23, 2025 at 7:18 PM
🚨Does Vaping Cause Lung Cancer? Myths and Facts🚨
14.1% of young adults (18-25) — around 4.7 million people — are vaping, putting their health at serious risk. Studies show that vaping combined with smoking increases the risk of lung cancer 4x.
14.1% of young adults (18-25) — around 4.7 million people — are vaping, putting their health at serious risk. Studies show that vaping combined with smoking increases the risk of lung cancer 4x.
